During endochondral ossification in the vertebrate limb, multipotent mesenchymal cells first differentiate into chondroblasts (chondrogenesis) that further differentiate (via chondrocyte hypertrophy) to a terminal cellular phenotype. Dlx5 and Dlx6 are functionally redundant regulators of chondrocyte hypertrophy. We now show that Dlx5 and Dlx6 also regulate the earlier step of chondrogenesis in the limb. Limb bud mesenchymal cells from Dlx5/6 À/À embryos show reduced chondrogenesis compared to wild-type littermates, and expression of either Dlx5 or Dlx6 stimulated differentiation of limb bud mesenchymal cells to chondroblasts. The functional overlap between Dlx5 and Dlx6 occurs despite the fact that the amino-and carboxyl-terminal domains of the encoded proteins are dissimilar. In order to reconcile the disparity between the divergent structures of Dlx5 and Dlx6 with their overlapping biological functions, we investigated the domain requirements and transcriptional activities associated with Dlx5-and Dlx6-mediated chondrogenesis. We find distinct domain requirements for the chondrogenic function of these related homeoproteins, indicating divergent molecular mechanisms of action.
Introduction
The Dlx gene family encodes an important group of developmental regulatory proteins that have evolved via the duplication and retention of Distal-less (Dll) genes (Stock et al., 1996; . The likely scenario of Distal-less duplication during vertebrate evolution involves an initial inverted repeat to form a bigene cluster of convergently transcribed Dlx transcription units, followed by a period of divergence between sister genes, then two larger scale duplications involving the whole bigene cluster(s). This scenario is consistent with the genomes of extant mammals wherein six Dlx genes are arranged as three bigene clusters on different chromosomes with the Dlx2, Dlx3, and Dlx5 paralogues being more closely related to each other than each is to their cis-linked sister gene (Dlx1, Dlx4, and Dlx6, respectively) (Stock et al., 1996) . Several highly conserved non-coding sequence elements have been identified in the 10-17 kb intergenic regions of Dlx bigene clusters and have been shown to behave as tissue-specific enhancers (Ghanem et al., 2003; Park et al., 2004) . Intergenic enhancer sharing therefore seems to account for much of the overlap in expression of members of a Dlx bigene cluster.
Dlx5 and Dlx6 are expressed throughout the developing skeleton and have been implicated in the differentiation of a variety of mineralising cell types, including teeth, bone, and cartilage. For example, Dlx5 and Dlx6 are expressed in the developing murine dentition (Zhao et al., 2000) and Dlx5 À/À neonates show hypomineralized molars (Depew et al., 1999) . Within the intramembranous skeleton, Dlx5 is expressed in differentiating osteoblasts and is down-regulated in mature osteocytes. Consistent with a role as a positive regulator of osteogenesis (Acampora et al., 1999) , Dlx5 À/À mice show delayed ossification of the parietal and interparietal bones of the dermatocranium (Acampora et al., 1999; Depew et al., 1999 ) and a variety of cellular studies imply that Dlx5 acts as a positive regulator of osteoblast-specific genes (Dodig et al., 1996; Benson et al., 2000; Hullinger et al., 2001; Hassan et al., 2004) . Redundant roles for Dlx5 and Dlx6 during osteogenesis were revealed in Dlx5/6 À/À mice which lack calvarial bones altogether (Robledo et al., 2002) . In contrast to the dermatocranium and clavicles, much of the skeleton develops via a cartilaginous intermediate. In the early limb bud, the aggregation of pluripotent mesenchymal precursor cells and their overt differentiation to chondroblasts (chondrogenesis) represents the first definitive stage of appendicular skeletogenesis. The subsequent differentiation of proliferative chondroblasts to hypertrophic and terminally differentiated mineralising chondrocytes occurs in a highly regulated spatial and temporal fashion that coordinates the growth of cartilaginous elements and their ossification to a bony skeleton. Dlx5 is expressed from the earliest stages of endochondral skeletal development, being noted in precartilaginous limb bud mesenchyme (Zhao et al., 1994; Ferrari et al., 1995; Bendall et al., 2003) and, later, in the perichondrium/periosteum of more mature cartilages in the limb as well as ribs and vertebrae (Simeone et al., 1994; Chen et al., 1996; Acampora et al., 1999; Bendall et al., 2003) . Dlx6 expression was also originally noted in the periosteum of developing ribs (Simeone et al., 1994) .
Dlx5
À/À embryos and neonates show a modest defect in chondrocyte hypertrophy in the long bones of the limbs (Bendall et al., 2003) , while targeted deletion of both Dlx5 and Dlx6 resulted in more pronounced deficiencies in chondrocyte hypertrophy (Robledo et al., 2002) . Reciprocally, misexpression of Dlx5 in chick embryo wing buds resulted in regions of ectopic chondrocyte hypertrophy (Ferrari and Kosher, 2002) and misexpression of Dlx5 in chondrogenic cell lines stimulated their differentiation in vitro (Bendall et al., 2003) . Together, these experiments implicated Dlx5 and Dlx6 as partially redundant positive regulators of chondrocyte hypertrophy in the appendicular skeleton.
Further evidence of functional overlap between Dlx5 and Dlx6 has been seen in the craniofacial and limb patterning phenotypes of Dlx5 and Dlx5/6 null mice (Acampora et al., 1999; Depew et al., 1999 Depew et al., , 2002 Beverdam et al., 2002; Merlo et al., 2002; Robledo et al., 2002; Bendall et al., 2003) . Functional overlap has also been documented between the Dlx1 and Dlx2 gene pair, which are co-expressed in the forebrain and branchial arches (Qiu et al., 1997; Eisenstat et al., 1999) . Targeted deletion of both Dlx1 and Dlx2 generates a more severe neuronal and craniofacial phenotype compared with the loss-offunction of either gene alone (Qiu et al., 1995 (Qiu et al., , 1997 ). An intriguing situation therefore exists among Dlx genes; cislinked pairs of genes that show overlapping expression domains and significant functional redundancy encode related transcription factors that are nonetheless considerably divergent in the sequences of their amino-and carboxyl-terminal domains.
Here, we show a novel contribution of Dlx5 and Dlx6 to skeletal development; namely, in regulating the initial differentiation of multipotent limb bud mesenchymal cells to the chondrocyte lineage. Dlx5 and Dlx6 are co-expressed in chondrogenic limb bud mesenchyme during chick development and, like Dlx5, misexpression of Dlx6 stimulated chondrogenesis in limb bud mesenchymal cells. Intriguingly, in light of the sequence disparity between the Dlx5 and Dlx6 proteins, we find that different protein domains are involved when comparing Dlx5-and Dlx6-mediated chondrogenesis, indicating divergent molecular mechanisms of action.
Results

Dlx5 and Dlx6 contribute to chondrogenesis in the murine appendicular skeleton
The expression of Dlx5 in the chondrogenic mesenchyme of limb buds (Bendall et al., 2003) and the demonstrated redundancy between Dlx5 and Dlx6 for regulating chondrocyte hypertrophy (Robledo et al., 2002; Bendall et al., 2003) , led us to ask whether a role for these genes in chondrogenesis would be revealed in embryos doubly null for Dlx5 and Dlx6. To test whether Dlx5 and Dlx6 are required for chondrogenesis, embryos were recovered from timed Dlx5/6 +/À matings between 10.5 and 12.5 days post coitum (dpc) and stained with alcian blue. Limbs of Dlx5/6 À/À embryos showed reduced alcian blue staining compared to wild-type littermates, indicating that fewer mesenchymal cells were differentiating to chondroblasts in the absence of Dlx5 and Dlx6 activity (Fig. 1A) . To more readily quantitate this difference, micromass assays of limb bud mesenchymal cells from 11.5 to 12.5 dpc embryos were done to assess chondrogenesis in vitro. Foreand hind-limb buds were dissected and mesenchymal cells were isolated and cultured at high density. Large numbers of cartilaginous nodules formed from wild-type limb mesenchymal cells over four days of micromass culture, as revealed by alcian blue staining. Cultures done from the limb buds of Dlx5 À/À embryos did not show a significant difference in nodule number compared to wild-type littermates (data not shown). In contrast, mesenchyme from Dlx5/6 À/À embryonic limbs at either stage showed a much-reduced capacity to form chondrogenic nodules, with a 50-60% reduction in nodule number (Fig. 1B and C, and data not shown). Dlx5/6 À/À embryos start to show limb outgrowth defects as a result of regression of the apical ectodermal ridge from 11.5 dpc (Robledo et al., 2002) . We therefore asked whether the reduction in chondrogenesis in Dlx5/6 À/À limbs was an indirect effect due to defects in mesenchymal cell proliferation and/or survival. We plated equal numbers of limb bud cells from individual embryos in 96-well plates and measured cell number each day for three days. We did not detect any defects in cell proliferation or survival of limb bud cells from 11.5 dpc Dlx5/6
À/À embryos compared to wild-type or heterozygous littermates. For limb bud cells of all three genotypes, cell number almost doubled in the first 24 h and then remained stable over the remaining two days (Fig. 1D) . Thus, Dlx5 and Dlx6 make a direct contribution to the differentiation Representative dissected hindlimbs are shown from 2 litters examined at 11.5 dpc (4 null, 15 wild-type or heterozygous embryos). Note that hindlimbs from Dlx5/6 À/À embryos are shaped somewhat differently compared to developmentally equivalent wild-type littermates because of the effect of AER regression. (B) Dissociated limb bud mesenchymal cells from individual embryos at 11.5 dpc were cultured at high density for four days then stained with alcian blue to reveal chondrogenic nodule formation. A representative assay is shown from 3 litters examined (4 null embryos, 6 cultures total, 13 wild-type or heterozygous embryos, 22 cultures total). (C) Quantitation of the data in B. Relative nodule number ± sem is plotted for 11.5 dpc Dlx5/6 À/À limb bud mesenchymal cells (grey bar) compared to wild-type and heterozygous littermates (black bar, set at 1.0). *P < 0.01, one-sided t test. (D) Cell proliferation of limb bud mesenchymal cells. Dissociated limb bud mesenchymal cells from individual embryos at 11.5 dpc were plated and cell number quantitated over three days. Averaged data from all four litters (5 null and 17 wild-type or heterozygous embryos) is plotted as relative cell number ± sem for wild-type or heterozygous (black line) and Dlx5/6 À/À littermates (grey line). Scale bar: 0.5 mm.
of multipotent limb mesenchymal precursors to the chondrogenic lineage in addition to their previously described role in the subsequent maturation of chondroblasts to hypertrophic chondrocytes.
Dlx5 and Dlx6 expression is co-localized in chondrogenic mesenchyme of embryonic chicken limbs
We have previously shown that Dlx5 is expressed in chondrogenic mesenchyme in the limb in a domain that coincides with expression of Sox9 (Bendall et al., 2003) . The activation of Col2a1 expression by Sox9 in this region marks the appearance of chondroblasts (Bell et al., 1997; Ng et al., 1997) . To determine whether regulation of chondrogenesis was a shared function of Dlx5 and Dlx6 in chicken limb development as well, we first examined the expression of Dlx6 in early stage chicken limb buds. Adjacent transverse cryosections from Hamburger and Hamilton stage 20 to 26 (st20-26) chicken embryos at the level of the forelimb buds were hybridized with antisense riboprobes against Dlx5, Dlx6, and Sox9. We observed lowlevel expression of Dlx6 in an area that corresponded to expression of Dlx5 and Sox9 on adjacent tissue sections of early limb buds (Fig. 2) . Therefore, like Dlx5, Dlx6 is expressed during chondrogenesis in the chicken limb bud.
Dlx6 stimulates chondrogenesis in limb bud mesenchymal cells
Misexpression of Dlx5 stimulated the differentiation of primary limb bud mesenchymal cells to chondroblasts in micromass cultures (Bendall et al., 2003) . Overlapping expression of Dlx5 and Dlx6 in chicken embryo limb bud mesenchyme suggests that Dlx6 is a pro-chondrogenic regulator during chicken embryogenesis as well. To test this hypothesis and compare the activity of chicken Dlx6 with Dlx5, we made a replication-competent avian retrovirus encoding chicken Dlx6 (RCAS-Dlx6) in order to misexpress the gene in primary limb bud cells in vitro. Dissociated pluripotent mesenchymal cells from st21-23 chick limb buds were infected with RCAS-Dlx6 or RCAS-Dlx5 virus prior to culturing at high density. As a basal control we infected cultures with an empty RCAS virus or one encoding human placental alkaline phosphatase (RCAS-AP), which behaved equivalently in this assay. Dlx6 stimulated chondrogenesis to a similar level as the chicken Dlx5 gene, with approximately twice as many nodules formed compared to cultures infected with RCAS-AP ( Fig. 3A and B) . In all cultures, there was a range of nodule sizes and the average size of Dlx6-or Dlx5-stimulated nodules was not significantly different from those in control cultures. Thus, both Dlx5 and Dlx6 have a similar pro-chondrogenic activity.
To address the mechanism of action of Dlx5 and Dlx6 on chondrogenic differentiation, we asked whether misexpression of either gene would be sufficient to induce nodule formation at sub-optimal (low) cell densities. Limb bud mesenchymal cells were cultured at initial densities that varied 2-fold from 5 · 10 6 to 4 · 10 7 cells/ml. We observed no or very few nodules in empty RCAS-infected cultures at 5 · 10 6 or 1 · 10 7 cells/ml ( Fig. 3C ) and neither Dlx5 nor Dlx6 misexpression permitted nodule formation under Fold-difference in alcian blue stained nodule number between cultures misexpressing Dlx5 (light bars) or Dlx6 (dark bars) compared to those infected with empty RCAS (set at 1.0). The experiment was done three times, each in triplicate. A representative experiment is shown; means ± sem. Significant differences (one-sided t test) between cultures misexpressing either Dlx5 or Dlx6 compared to RCAS-infected cultures at the same cell density are indicated. (E) Chicken Dlx5 and Dlx6 proteins. Individual domains were aligned using a pair-wise alignment algorithm (NeedlemanWunsch). Numbers indicate the percent identity (first) and similarity (second) for each domain. Identical residues are highlighted in red. CTD, carboxylterminal domain; HD, homeodomain; NTD, amino-terminal domain. c these conditions (Fig. 3D) . In contrast, at the higher cell densities, where significant numbers of nodules formed in RCAS-infected cultures, Dlx5 and Dlx6 misexpression further increased nodule number by up to 60% (Fig. 3D) . Thus, both Dlx5 and Dlx6 appear to stimulate chondroblast differentiation downstream of mesenchymal cell aggregation.
Comparison of the domain structure of Dlx5 and Dlx6 reveals that, while their homeodomains are substantially equivalent, the two proteins are striking dissimilar in their amino-and carboxyl-terminal domains (NTD and CTD, respectively, Fig. 3E ). Given the reduced homology between cis-linked Dlx5 and Dlx6 paralogues, we next investigated the domain requirements of each protein for their chondrogenic function to address whether protein sequences other than the conserved homeodomain were contributing to the shared pro-chondrogenic activities of these proteins.
Differential domain requirements for Dlx5-and Dlx6-mediated chondrogenesis
To map the domain requirements for the pro-chondrogenic function of Dlx5 we made retroviruses encoding truncated Dlx5 polypeptides as well as retroviruses encoding chimeric polypeptides in which the missing Dlx5 domain was replaced with a defined transcriptional activation or repression domain ( Fig. 4A and B) . These retroviruses were used to infect limb bud mesenchymal cells at the time of plating and the ability of the encoded polypeptide to stimulate chondrogenesis was quantitated by counting alcian blue-positive nodules after four days of culture and comparing to the basal levels in parallel RCAS-infected cultures. A truncated Dlx5 polypeptide consisting of the NTD and homeodomain (Dlx5DC) stimulated chondrogenesis at least as well as full-length Dlx5 whereas Dlx5DN did not stimulate nodule formation over basal levels (Fig. 4C) . Substitution of the Dlx5 NTD with a transcriptional repression domain from Drosophila Engrailed (EnR) created a small dominant negative effect, such that nodule numbers were reduced below basal levels. In contrast, substitution with an activation domain (VP16) rescued the ability of the Dlx5 homeodomain plus CTD to stimulate chondrogenesis (Fig. 4C) . Together, these data indicate that the Dlx5 NTD supplies a transcriptional activation activity to stimulate limb bud mesenchyme to differentiate along the chondrogenic pathway. To address what role, if any, the homeodomain was playing in stimulating chondrogenesis, we misexpressed a Dlx5 protein with amino acid substitutions in the amino-terminal arm of the homeodomain (Dlx5HD m ) that is defective in DNA binding (Bendall et al., 2003) . This resulted in a Dlx5 protein that was unable to stimulate chondrogenesis in vitro (Fig. 4C) . Thus, the Dlx5 NTD is not sufficient to stimulate chondrogenesis when DNA binding is compromised.
An equivalent analysis was applied to Dlx6 by truncating amino-or carboxyl-terminal domains and replacing them with transcriptional domains of defined activity ( Fig. 5A and B) . Deletion of the NTD of Dlx6 rendered a partially active protein with significantly less activity than full length Dlx6 (Fig. 5C ). Full activity was restored by substituting a transcriptional activation domain but not a repression domain (Fig. 5C and data not shown) . Thus, like Dlx5, transcriptional activation supplied by the NTD of Dlx6 is important for the pro-chondrogenic function. In contrast to Dlx5 however, removing the CTD of Dlx6 completely abolished its ability to stimulate nodule formation. Again, the ability to stimulate chondrogenesis was restored by substitution with a transcriptional activation domain but not a repression domain (Fig. 5C and data not shown). In Dlx6, the CTD therefore supplies a critical transcriptional activation activity for chondrogenesis, while an intact NTD is required for full activity. Finally, we asked whether the Dlx6 CTD would function in a heterologous context. Thus, we generated an RCAS virus encoding a chimeric Dlx protein consisting of the NTD and homeodomain of Dlx5 fused to the Dlx6 CTD. This polypeptide stimulated chondrogenesis in a micromass assay to a level equivalent to wild-type Dlx6 (Fig. 5C ), indicating an additive effect of the Dlx5 NTD and the Dlx6 CTD within this chimeric protein.
Characterizing endogenous transcriptional domains of Dlx5 and Dlx6
In all cases, depletion of the pro-chondrogenic activity of Dlx5 or Dlx6 by truncation of the proteins could be rescued by substituting a heterologous transcriptional activation domain. We next asked whether this represented the endogenous activities of these domains. The cytomegalovirus immediate early promoter contains two Dlx consensus binding sites (TAATT) centred 89 bp apart in an inverted orientation and luciferase reporter plasmids containing this basal promoter respond to Dlx5 in a dose-dependent manner (D.E.A. and A.J.B., unpublished data). We therefore used this configuration to measure the transcriptional activities of Dlx5 and Dlx6 domains in HEK293 cells. Dlx5 activated transcription of this reporter about 10-fold over basal levels (Fig. 6) . Removal of the CTD resulted in a much stronger activation, to about 50-fold. The Dlx5 homeodomain alone had minimal activity and the CTD showed a 5-fold activation of the reporter, lower than full length Dlx5 (Fig. 6) . The NTD of Dlx5 therefore contains a potent transactivation domain, which is partially masked by the CTD in the full length protein. Dlx6 activated the reporter to similar levels as Dlx5, however the individual amino-and carboxyldomains each stimulated transcription by about 25-fold in the absence of the other domain. Like Dlx5, the Dlx6 homeodomain showed no significant activation of the reporter (Fig. 6) . Thus, the contribution of each Dlx protein domain to stimulating chondrogenesis paralleled its activity as a transcriptional activation domain on a Dlx-responsive promoter.
Discussion
Dlx5 and Dlx6 as multi-functional regulators of chondrocyte differentiation
Endochondral ossification, in which cartilaginous anlagen are progressively replaced by definitive bone, represents the dominant mode of development of the trunk and limb skeleton. Development of the endochondral skeleton involves an exquisite balance between competing extracellular signals and nuclear transcription factors that promote proliferation, lineage commitment, and differentiation to discrete chondrogenic fates to coordinate longitudinal bone growth and joint articulation. Activation and to 23 chicken embryos were mixed with RCAS virus or an RCAS encoding the polypeptides shown in A, plated at 2 · 10 7 or 4 · 10 7 cells/ml and cultured for four days. Results plotted as fold-difference in alcian blue stained nodule number between cultures misexpressing the Dlx5-based polypeptide shown, compared to parallel cultures infected with empty RCAS in the same experiment (set at 1.0). Each bar represents the means ± sem from between three and nine independent experiments, each done in triplicate (Dlx5, n = 9; Dlx5DC, n = 5; Dlx5DN, n = 7; EnRDlx5, n = 3; VP16Dlx5, n = 7; Dlx5HD m , n = 3). Significant differences (one-sided t test) between cultures infected with RCAS encoding Dlx5 polypeptides compared to empty RCAS are indicated.
integration of these signals results in intracellular cascades that ultimately regulate transcriptional events responsible for appropriate embryonic development and adult function of the skeleton.
In this study, we have shown that reduced chondrogenesis is a phenotypic consequence of ablating Dlx5 and Dlx6 function in the mouse. Together with the earlier data, implicating these homeobox genes in the control of 7 or 4 · 10 7 cells/ml and cultured for four days. Results plotted as fold-difference in alcian blue stained nodule number between cultures misexpressing the polypeptide shown, compared to parallel cultures infected with empty RCAS in the same experiment (set at 1.0). Each bar represents the means ± sem from between 3 and 11 independent experiments, each done in triplicate (Dlx6, n = 11; Dlx6DC, n = 5; Dlx6VP16, n = 3; Dlx6DN, n = 9; VP16Dlx6, n = 3; Dlx5/6, n = 5). Significant differences (one-sided t test) between cultures infected with RCAS encoding Dlx6 polypeptides compared to empty RCAS are indicated, as is the difference between cultures infected with RCAS-Dlx6 compared to RCAS-Dlx6DN. chondrocyte hypertrophy, it appears that Dlx5 and Dlx6 act on at least two steps of the chondrocyte maturation pathway, namely the initial differentiation of multipotent mesenchymal cells to proteoglycan-secreting chondroblasts as well as the transition from a mitotically active prehypertrophic chondrocyte to a non-dividing hypertrophic chondrocyte (Ferrari and Kosher, 2002; Robledo et al., 2002; Bendall et al., 2003) . Superficially, our results appear to be at odds with those of McKeown et al. (2005) in which misexpression of Dlx2 in pharyngeal ectomesenchyme enhanced cell condensation to the extent that chondrogenesis was actually inhibited. Instead, this may represent an important difference in the response to Dlx misexpression between lateral plate mesoderm-and neural crest-derived chondroprogenitor cells.
Dlx5 and Dlx6 are not equally expressed in the chondrogenic limb bud mesenchyme, with Dlx5 being expressed at significantly higher levels (Fig. 2) . Dlx6 expression levels were higher in other embryonic tissues we examined but, wherever Dlx5 and Dlx6 expression overlapped, Dlx6 expression was lower compared to Dlx5. Indeed, where expression has been directly compared, one member of each bigene cluster (Dlx1, -4, -6) is usually expressed at lower levels than the other (Dlx2, -3, -5, respectively) (Liu et al., 1997, and H.Z., A.J.B. unpublished data) . Since this relationship follows Dlx clade organization, it suggests that there is some consistent directionality in the action of intergenic enhancers.
Dlx5 and Dlx6 appear to exert their effects on chondroblast differentiation downstream of mesenchymal cell aggregation since misexpression of neither gene was permissive for chondrogenic nodule formation under conditions of sub-optimal (low) cell density. Consistent with this, nodules did not appear earlier when either Dlx5 or Dlx6 were misexpressed compared to control cultures.
The effects of Dlx5 and Dlx6 on limb chondrogenesis are in contrast to the effects of Sox9, and another homeobox gene Barx2, which appear to stimulate chondrogenesis by a mechanism that enhances mesenchymal cell aggregation (Healy et al., 1999; Meech et al., 2005) . Dlx5 and Dlx6 instead appear to function in overt chondrogenic differentiation rather than mesenchymal cell aggregation. Reduced chondrogenesis in the absence of Dlx5 and Dlx6 function is therefore consistent with the previous observation that Sox9 expression was not affected in the early limb buds of Dlx5/6 À/À embryos (Robledo et al., 2002) since Dlx gene function is unlikely to be upstream of Sox9 expression. Given that Sox genes and Barx2 have been implicated in multiple steps of chondroblast differentiation (Akiyama et al., 2002; Meech et al., 2005) , further studies that explore the epistatic and functional relationships between these early acting transcription factors are warranted.
As is true for many families of vertebrate regulatory proteins, it is not clear to what extent different Dlx proteins are functionally distinct and to what extent they represent expression variants required to fulfil a generic Dlx function. The Gallus Dlx5 and Dlx6 proteins represent divergent products of a long vertebrate ancestry and belong to different clades of the Dlx family (Stock et al., 1996) . We note that the NTD of murine Dlx5 and Dlx6 are even more dissimilar (20.8% identity, 30.6% similarity) due to trinucleotide expansions, involving codons for glutamine and alanine, in mammalian Dlx6 genes (Pfeffer et al., 2001) . Despite this diversification, both Dlx5 and Dlx6 proteins stimulated the differentiation of pluripotent mesenchyme to chondroblasts to a similar degree. Analysis of the transcriptional activities of the amino-and carboxyl-terminal domains revealed that the pro-chondrogenic activity of either protein is reconcilable in terms of the contribution each domain makes to transcriptional activation. Thus, the NTD contains the majority of the transcriptional activity of Dlx5 and is also the critical domain for Dlx5-mediated chondrogenesis. Alternatively, transcriptional activity is more dispersed in Dlx6, with both NTD and CTD contributing to target gene activation and chondrogenesis. In either case, the prochondrogenic activity of the carboxyl-and/or amino-terminal domains of Dlx5 and Dlx6 appears to be dependent on the conserved homeodomain for binding to appropriate cis regulatory elements. While these data highlight the flexibility of Dlx proteins to accommodate significant amino acid sequence divergence while maintaining discrete biological functions, the data herein also imply that different Dlx proteins may have evolved different molecular strategies for fulfilling those functions. Given the differential domain requirements for Dlx5-and Dlx6-mediated chondrogenesis, it is not clear that the Dlx5-and Dlx6-regulated targets are exactly the same. Even if they are, it seems likely that Dlx5 and Dlx6 assemble into molecularly distinct yet functionally equivalent complexes on common Dlx-responsive promoters. These findings make a detailed understanding of individual Dlx protein interaction with cell type-specific cofactors of particular interest. Each bar represents the means ± sem from between 3 and 12 independent experiments, each done in triplicate (Dlx5, n = 12; Dlx5DC, n = 7; Dlx5DN, n = 8; Dlx5HD, n = 4; Dlx6, n = 11; Dlx6DN, n = 7; Dlx6DC, n = 8; Dlx6HD, n = 3; Dlx5/6, n = 5).
Dlx gene evolution and the appendicular skeleton
Development of a chondrogenic endoskeleton defines the vertebrates. Genes that regulate the differentiation of chondroblasts from axial and lateral plate mesoderm must therefore have evolved in a basal vertebrate ancestor at a time when there was also an abrupt increase in the gene copy number of developmental regulatory genes like Dlx. Consideration of developmental regulatory genes as mediators of the evolution of animal form has typically emphasized changes in regulatory elements that alter sites of expression over changes in the protein-coding sequence that alter protein function (Carroll, 2000, but see Alonso and Wilkins, 2005 for an alternative view). The differential domain requirements for chondrogenic differentiation by Dlx5 and Dlx6 suggest that an original Distal-less gene in a common ancestor of bilaterians was 'pre-adapted' to fulfil a pro-chondrogenic role in vertebrates and that acquisition of a novel Dlx expression domain in the mesoderm was likely to have been the key event that led to the cooption of Dlx genes to appendicular skeletal differentiation. Indeed, mesodermal expression of Dlx genes appears to be a derived state in deuterostomes, with expression being reported in mesodermal cell types in echinoderms (Lowe and Wray, 1997) and non-gnathostome chordates (Caracciolo et al., 2000; Neidert et al., 2001) . Thus, following the original Dlx gene duplication event, which is likely to have occurred sometime after the last common ancestor of chordates (Stock et al., 1996; Neidert et al., 2001; , subsequent divergence of the original cislinked Dlx gene pair may have occurred in such a way as to retain this ancestral function. It is difficult to reconcile the biochemical diversity within the extant mammalian Dlx protein family with the alternative scenario in which independent acquisition and retention of discrete cell type-specific differentiation activities occurred in individual Dlx proteins after gene duplication.
What remains to be considered is to what extent acquisition of a novel expression domain in lateral plate mesenchyme expanded the repertoire of genes regulated by Dlx transcription factors. Re-stated, is the contribution of Dlx genes to limb chondrogenesis largely mediated by a pre-existing set of generic Dlx-regulated ''anti-proliferation/pro-differentiation'' genes or by novel genes encoding cell type-specific products? While no direct targets of Dlx5 or Dlx6 have been identified in chondrogenic limb mesenchyme or chondroblasts, Dlx5 has been implicated in the direct regulation of a variety of osteoblast-specific genes that represent novel vertebrate genes of the skeleton (Dodig et al., 1996; Benson et al., 2000; Hullinger et al., 2001; Hassan et al., 2004) . The identification of Dlx target genes in chondrogenic limb mesenchyme and prehypertrophic chondrocytes will permit comparisons of the mode of action of Dlx proteins in chondroblast versus osteoblast differentiation and provide further insight into this aspect of Dlx gene function.
Experimental procedures
Plasmids
The chicken Dlx6 cDNA sequence was deduced from two overlapping ESTs: Genbank Accession No. BM488252 and clone ChEST406p23 from the chicken expressed sequence tag data repository (Hubbard et al., 2005) . The open reading frame (ORF) was subsequently amplified by reverse transcription coupled polymerase chain reaction from Hamburger and Hamilton stage 29 to 30 chicken embryonic forebrain. Chicken Dlx5 ORF was amplified by PCR from a previously cloned sequence (Bendall et al., 2003) . cDNAs encoding full-length or truncated Dlx polypeptides were cloned as BamHI-HindIII or BamHI-XbaI fragments downstream of two tandem c-Myc epitopes (EQKLISEEDL with a GS linker) and further subcloned into pcDNA3 (Invitrogen) as EcoRI-ApaI or XbaI-ApaI fragments for mammalian expression or into a modified pSlax13 (Zhu and Bendall, 2006) as EcoRI-HindIII or NcoI-HindIII fragments for retroviral-mediated expression in avian cells. Amino-terminal domain substitutions: the activation domain (amino acid 412-490) of the HSV-1 transactivator VP16 and the repression domain (amino acid 2-298) from the Drosophila Engrailed protein were amplified from cloned sequences and cloned downstream of two c-Myc epitopes as BamHI-ApaI fragments. Epitope-tagged sequences were re-amplified and cloned into pSlax13 as NcoI-EcoRI fragments, containing a 3 0 XhoI site immediately upstream of a termination codon. Dlx-encoding sequences were subsequently cloned downstream of VP16 or EnR as XhoI-ApaI fragments. Carboxyl-terminal domain substitutions: ''seamless'' carboxyl-terminal domain substitutions were engineered into Dlx coding sequences by PCR, wherein the coding region of interest was amplified in two pieces. The reverse primer for the 5 0 fragment and the forward primer for the 3 0 fragment incorporated 24 nucleotide tails complementary to the other fragment, thus generating two fragments that overlapped by 48 bp. Each PCR product was gel purified, combined in a single reaction and re-amplified with the same outside primers to reconstitute the chimeric coding sequence to its full length. Chimeric coding sequences were cloned as BamHI-HindIII fragments downstream of a double c-Myc epitope in the modified pSlax13. Chicken Dlx5/6 was made by exchanging the 3 0 end of the Dlx6 homeobox plus CTD-encoding sequence as an SfiI-HindIII fragment into pSlax-mycDlx5. All Myc-tagged cDNAs were subcloned as ClaI fragments into the replication-competent avian retroviral vector RCASBP(A) (Hughes et al., 1987) for infection of primary chicken cells. The sequences of all PCR products were verified by sequencing.
In situ hybridization
Section in situ hybridization on embryonic limbs between stages 20 and 28 was done as described (Zhu and Bendall, 2006) . Antisense Dlx6 riboprobe (804 nt) was synthesized with SP6 RNA polymerase from a pGEM11-Dlx6 template linearized with BamHI. Antisense Dlx5 riboprobe (860 nt) was synthesized with T7 RNA polymerase from a pBluescriptSK-Dlx5 template linearized with BamHI (Bendall et al., 2003) . Antisense Sox9 riboprobe (381 nt) was synthesized with T7 RNA polymerase from a pCRscript-Sox9 template linearized with SacII (Kent et al., 1996) .
Production of avian retroviruses
Retroviruses used in this study were generated using a modified protocol (Bendall et al., 2003) . 4 · 10 7 cells/ml primary chicken embryonic fibroblasts (Line 0 White Leghorn, SPAFAS) were seeded in a 176 cm 2 tissue culture dish and transfected with 24 lg RCAS plasmids and Lipofectamine 16-24 h later. Transfected cells were passaged in a single 1:4 split and allowed to reach confluence before viruses were collected in low serum medium (DMEM supplemented with 1% fetal bovine serum (FBS), 0.2% chicken serum, 2 mM L-glutamine, without antibiotics). Concentrated viral stock used in this study had titres between 5 · 10 8 and 2 · 10 9 cfu/ml.
Western blotting
Whole cell extracts of virus-infected DF-1 cells were made with a high salt buffer (500 mM NaCl, 1% NP-40, 50 mM Tris, pH 8) containing a protease inhibitor cocktail (complete, Mini, EDTA-free, Roche). 100 lg protein were separated by 13.5% SDS-PAGE, transferred to Immobilon membrane (Millipore) and probed with 1:5000 anti-Myc antibody (HRP-conjugated, Invitrogen).
Chondrogenesis assays
Embryos were fixed in 95% ethanol for 1 week, stained with 0.5% alcian blue 8GX (pH 1), rehydrated through an ethanol series and briefly cleared (10-20 min) in 1% KOH before photography. Fore-and hindlimbs were dissected from 11.5 to 12.5 dpc mouse embryos and collected in growth medium (DMEM + 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100 lg/ml streptomycin), washed twice in phosphate-buffered saline (PBS), and digested in 0.1% trypsin and 0.1% collagenase (Worthington Biochemical) in PBS at 37°C for 20-30 min. 20 ll of a single cell suspension (2 · 10 7 cells/ml) was plated in the center of 9.6 cm 2 dishes. The cultures were incubated at 37°C in a humidified incubator with 5% CO 2 for 1 h, after which they were gently flooded with 2 ml of growth medium. Medium was changed every 48 h. Cultures were incubated for 4 days, and then fixed in 3% paraformaldehyde. Chondrocyte differentiation was visualized by staining with 0.5% alcian blue 8GX (pH 1) and total nodule numbers counted. Forelimb buds were dissected from HH stage 23 to 24 chicken embryos and collected in Ca 2+ , Mg
2+
-free Puck's Saline G (CMF-PSG: 0.8% NaCl, 0.04% KCl, 0.029% Na 2 HPO 4 , 0.015% KH 2 PO 4 , and 0.11% glucose) and digested in 0.1% collagenase and 0.1% trypsin with 10% chicken serum in CMF-PSG at 37°C for 10 min. Ten microliters of a single cell suspension (typically at 2 · 10 7 cells/ml) were infected with 10 ll of concentrated avian retroviruses (5 · 10 8 À 1.5 · 10 9 iu/ml) in growth medium containing 8 lg/ml polybrene in the center of 9.6 cm 2 dishes then cultured, stained and counted as above.
Cell proliferation assays
1.25 · 10 5 cells/well from 11.5 dpc fore-and hind-limb buds were plated in 100 ll growth medium in 96-well plates. Cells were allowed to attach, then 100 ll of a 10% solution of alamar blue (BioSource, Camarillo, CA) prepared in growth medium was added. Cell number was quantitated by measuring the reduction of alamar blue in a microplate fluorescence reader using 516/20 excitation and 590/35 emission filters. Fluorescence was measured immediately to obtain background readings and the cells were incubated for 5 h at 37°C at which time the fluorescence was measured again. The assay was performed every 24 h for 3 days to generate growth curves.
Transcription assays
HEK293 cells were maintained in DMEM supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 lg/ml streptomycin in a humidified incubator at 37°C, 5% CO 2 . 1 · 10 5 cells were seeded per well in a 24-well plate and transfected the following day with pcDNA3-Dlx expression plasmids, pGL3-Promoter (Promega), and CMV-bGal (Spaete and Mocarski, 1985) using 2 lg polyethylenimine (Sigma) per lg DNA in serum-free DMEM. Cell extracts were made 48 h post-transfection using Reporter lysis buffer (Promega) and used to measure luciferase activities in a luminometer according to the manufacturers instructions and bgalactosidase activity using a standard protocol (Sambrook et al., 1989) .
